( September 3, 2025, 4:29 PM EDT) -- SAN FRANCISCO — A California federal judge set an August 2027 trial date for a case filed by seven individuals who allege that Oxbryta (voxelotor), a prescription medication used for the treatment of sickle cell disease (SCD), was ineffective and will hear arguments on whether class certification is warranted in June 2026....